Showing results (1-10 of 1,332) with videos related to
Sort By:
Pageof 134
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2005
New targeted approaches in chronic myeloid leukemiaJorge Cortes, Hagop KantarjianCancer|May 13, 2004
Beyond chronic myelogenous leukemia: potential role for imatinib in Philadelphia-negative myeloproliferative disordersJorge Cortes, Hagop KantarjianSeminars in Hematology|February 4, 2003
Advanced-phase chronic myeloid leukemiaJorge Cortes, Hagop KantarjianJournal of the National Comprehensive Cancer Network : JNCCN|August 9, 2008
Beyond dose escalation: clinical options for relapse or resistance in chronic myelogenous leukemiaJorge Cortes, Hagop KantarjianJournal of the National Comprehensive Cancer Network : JNCCN|August 9, 2008
BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: using guidelines to make rational treatment choicesHagop Kantarjian, Jorge CortesHematology. American Society of Hematology. Education Program|December 4, 2016
Chronic myeloid leukemia: sequencing of TKI therapiesJorge Cortes, Hagop KantarjianClinical Lymphoma, Myeloma & Leukemia|January 31, 2012
Molecular resistance: an early indicator for treatment change?Carmen Fava, Hagop Kantarjian, Jorge CortesCancer|October 15, 2010
Long-term outcomes in the second-line treatment of chronic myeloid leukemia: a review of tyrosine kinase inhibitorsElias Jabbour, Jorge Cortes, Hagop KantarjianLeukemia & Lymphoma|October 30, 2004
Clinical activity of farnesyl transferase inhibitors in hematologic malignancies: possible mechanisms of actionElias Jabbour, Hagop Kantarjian, Jorge CortesPageof 134